SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned

被引：0

作者：

Lytton, Simon D. ^{[1
]}

Ghosh, Asish Kumar ^{[2
]}

机构：

[1] SeraDiaLogistics, D-81545 Munich, Germany

[2] Dhaka Med Coll Hosp, Dept Virol, Dhaka 1000, Bangladesh

来源：

VIRUSES-BASEL | 2024年 / 16卷 / 07期

关键词：

Bangladesh; COVID-19; SARS-CoV-2; variants; vaccination coverage; pandemic preparedness; IMMUNE ESCAPE; CHALLENGES;

D O I：

10.3390/v16071077

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The coronavirus infectious disease-2019 (COVID-19) in Bangladesh is a paradigm for how one of the most densely populated countries in the world, with 1270 people per square kilometer, managed to cope with the COVID-19 pandemic under extraordinary circumstances. This review highlights the SARS-CoV-2 variants in Bangladesh and the timeline of their detection in the context of the global experience with the management of vaccination and natural SARS-CoV-2 infection. The motivation to overcome the COVID-19 vaccine dilemma and track Bangladeshi SARS-CoV-2 sub-variants underscores the potential for a low-income country to excel in international medical science, despite having stressed health care services and limited availability of resources for SARS-CoV-2 testing and gene sequencing.

引用

页数：15

共 84 条

[1] COVID-19 vaccination success in Bangladesh: Key strategies were prompt response, early drives for vaccines, and effective awareness campaigns [J].

Ahamed, Bulbul ;

Haque, Md. Anamul ;

Tanbir, Md. ;

Roknuzzaman, A. S. M. ;

Sarker, Rapty ;

Rabiul Islam, Md. .

HEALTH SCIENCE REPORTS, 2023, 6 (05)

[2] SARS-CoV-2 T Cell Responses Elicited by COVID-19 Vaccines or Infection Are Expected to Remain Robust against Omicron [J].

Ahmed, Syed Faraz ;

Quadeer, Ahmed Abdul ;

McKay, Matthew R. .

VIRUSES-BASEL, 2022, 14 (01)

[3] COVID-19 pandemic in Bangladesh: A scoping review of governance issues affecting response in public sector [J].

Ahmed, Syed Masud ;

Khanam, Mahruba ;

Shuchi, Noshin Sayiara .

PUBLIC HEALTH IN PRACTICE, 2024, 7

[4] A review of the genome, epidemiology, clinical features, prevention, and treatment scenario of COVID-19: Bangladesh aspects [J].

Al Noman, Abdullah ;

Islam, Md. Shofiqul ;

Sana, Samiron ;

Mondal, Prapti ;

Meem, Rima Islam ;

Rana, Sohel ;

Mondol, Debashish ;

Sana, Manoshi ;

Hossain, Sheikh I. ;

Joarder, Taufique ;

Mazumder, Kishor .

EGYPTIAN JOURNAL OF BRONCHOLOGY, 2021, 15 (01)

[5] What is the extent of COVID-19 vaccine hesitancy in Bangladesh? A cross-sectional rapid national survey [J].

Ali, Mohammad ;

Hossain, Ahmed .

BMJ OPEN, 2021, 11 (08)

[6]

Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]

[7] Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines [J].

Andrews, Nick ;

Tessier, Elise ;

Stowe, Julia ;

Gower, Charlotte ;

Kirsebom, Freja ;

Simmons, Ruth ;

Gallagher, Eileen ;

Thelwall, Simon ;

Groves, Natalie ;

Dabrera, Gavin ;

Myers, Richard ;

Campbell, Colin N. J. ;

Amirthalingam, Gayatri ;

Edmunds, Matt ;

Zambon, Maria ;

Brown, Kevin ;

Hopkins, Susan ;

Chand, Meera ;

Ladhani, Shamez N. ;

Ramsay, Mary ;

Bernal, Jamie Lopez .

NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (04) :340-350

[8]

[Anonymous], 2023, Bloomberg

[9] Assessment of COVID-19 management and its consequences on healthcare professionals: a cross-sectional study from Bangladesh [J].

Ara, Tasnim ;

Ferdous, Zannatul ;

Mahi, Mahfuza ;

Amin, Emama ;

Chowdhury, Sarah Binte ;

Shafiur Rahman, Md ;

Rahman, Lutfor ;

Rahman, Md Mahabubur .

BMJ OPEN, 2023, 13 (07)

[10]

Axfors C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22446-z

← 1 2 3 4 5 6 7 8 9 →